[Alpha-dihydroergocryptine; experiences--perspectives].
D004088:Dihydroergotoxine / Q000493:pharmacokinetics* / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D018491:Dopamine Agonists; D004088:Dihydroergotoxine